{
    "nct_id": "NCT03319459",
    "official_title": "FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors",
    "inclusion_criteria": "1. Regimen A only (monotherapy): Subjects with advanced metastatic solid tumors\n2. Regimen B only (combination with trastuzumab): Subjects with advanced metastatic HER2+ solid tumors\n3. Regimen C only (combination with cetuximab): Subjects with advanced metastatic EGFR+ solid tumors\n4. Available related donor who is CMV+ and HLA-haploidentical or better but not fully HLA-matched\n5. Presence of measurable disease by RECIST 1.1\n6. Life expectancy of at least 3 months.\n7. Provision of signed and dated informed consent form (ICF).\n8. Stated willingness to comply with study procedures and duration.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Females of reproductive potential that are pregnant or lactating, and males or females not willing to use a highly effective form of contraception from Screening through the end of the study.\n2. Eastern Cooperative Oncology Group (ECOG) performance status >2.\n3. Evidence of insufficient organ function as determined by the protocol.\n4. Receipt of any biological therapy, chemotherapy, or radiation within 1 week of the Screening Visit and at least 3 weeks prior to Day 1, except for patients receiving maintenance trastuzumab.\n5. Have central nervous system disease (CNS) as follows:\n\n   1. Dose Escalation Cohorts: Active CNS disease, including history of CNS metastases.\n   2. MTD/MFD Expansion Cohorts: CNS disease, including history of CNS metastases, that was not stable during the last 6 months.\n6. Myocardial infarction (MI) within 6 months of Screening Visit.\n7. Severe asthma.\n8. Currently receiving or likely to require systemic immunosuppressive therapy from Day -7 to Day 29.\n9. Uncontrolled infections.\n10. Presence of any medical or social issues that are likely to interfere with study conduct, or may cause increased risk to subject.",
    "miscellaneous_criteria": ""
}